Option Care Health (NASDAQ:OPCH) Issues FY 2024 Earnings Guidance

Option Care Health (NASDAQ:OPCHGet Free Report) updated its FY 2024 earnings guidance on Monday. The company provided earnings per share guidance of 1.550-1.590 for the period, compared to the consensus earnings per share estimate of 1.210. The company issued revenue guidance of $5.0 billion-$5.0 billion, compared to the consensus revenue estimate of $4.9 billion. Option Care Health also updated its FY 2025 guidance to 1.590-1.690 EPS.

Wall Street Analysts Forecast Growth

OPCH has been the topic of a number of recent research reports. Barrington Research boosted their price target on shares of Option Care Health from $32.00 to $33.00 and gave the stock an “outperform” rating in a research note on Tuesday. The Goldman Sachs Group cut Option Care Health from a “buy” rating to a “neutral” rating and cut their price target for the company from $38.00 to $27.00 in a research note on Monday, November 4th. UBS Group initiated coverage on shares of Option Care Health in a report on Thursday, December 5th. They issued a “neutral” rating and a $26.00 target price for the company. Jefferies Financial Group downgraded Option Care Health from a “buy” rating to a “hold” rating and dropped their price target for the stock from $38.00 to $26.00 in a research note on Thursday, October 31st. Finally, Bank of America raised shares of Option Care Health from a “neutral” rating to a “buy” rating and raised their price objective for the stock from $26.00 to $33.00 in a research report on Monday. Three investment analysts have rated the stock with a hold rating and four have given a buy rating to the company. According to data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $29.86.

Check Out Our Latest Analysis on OPCH

Option Care Health Stock Performance

Shares of OPCH stock opened at $28.72 on Wednesday. The stock has a 50 day simple moving average of $23.33 and a 200-day simple moving average of $27.70. The company has a market cap of $4.89 billion, a price-to-earnings ratio of 24.13, a price-to-earnings-growth ratio of 2.43 and a beta of 1.31. The company has a current ratio of 1.73, a quick ratio of 1.32 and a debt-to-equity ratio of 0.77. Option Care Health has a 12-month low of $21.39 and a 12-month high of $34.63.

Insiders Place Their Bets

In other news, Director Harry M. Jansen Kraemer, Jr. acquired 43,000 shares of Option Care Health stock in a transaction that occurred on Friday, November 8th. The stock was purchased at an average cost of $22.54 per share, with a total value of $969,220.00. Following the completion of the acquisition, the director now owns 326,334 shares in the company, valued at $7,355,568.36. This trade represents a 15.18 % increase in their position. The transaction was disclosed in a document filed with the SEC, which is available through the SEC website. Insiders own 0.64% of the company’s stock.

About Option Care Health

(Get Free Report)

Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn’s disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.

See Also

Receive News & Ratings for Option Care Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Option Care Health and related companies with MarketBeat.com's FREE daily email newsletter.